Changing perceptions of MGUS progression: explaining the data
Автор: VJHemOnc – Video Journal of Hematology & HemOnc
Загружено: 2019-10-25
Просмотров: 8016
Ola Landgren, MD, PhD, of Memorial Sloan Kettering Cancer Center, New York, NY, discusses his research into the progression of monoclonal gammopathy (MGUS) into multiple myeloma (MM), and the findings which indicate that risk assessment needs to be carried out more frequently. He also highlights how not all MGUS goes through a smoldering myeloma phase. This interview took place at the International Myeloma Workshop (IMW) 2019, in Boston, MA.
Доступные форматы для скачивания:
Скачать видео mp4
-
Информация по загрузке: